Screening of Patients with Psoriasis for Psoriatic Arthritis in the Slovak Republic

1. Parisi R, Symmons D, Griffiths C, Ashcroft D. Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence. Journal of Investigative Dermatology 2013; 133: 377–385.10.1038/jid.2012.339Search in Google Scholar

2. Pec J, Chromej I, Martinaskova K, Chribikova I, Danilla T. Chronicka loziskova psoriaza. Banska Bystrica: Dali-BB, s.r.o.; 2006. ISBN 80-89090-21-4.Search in Google Scholar

3. Mease PJ, Gladman DD, Papp KA, Khraishi MM, Thaci D, Behrens F, Northington R, Fuiman J, Bananis E, Boggs R, Alvarez D. Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics. J Am Acad Dermatol 2013; 69(5): 729–735.10.1016/j.jaad.2013.07.023Search in Google Scholar

4. Augustin M, Reich K, Glaeske G, Schaefer I, Radtke M. Co-morbidity and Age-related Prevalence of Psoriasis: Analysis of Health Insurance Data in Germany. Acta Derm Venereol 2010; 90: 147–151.10.2340/00015555-0770Search in Google Scholar

5. Wilson F, Icen M, Crowson C, McEvoy M, Gabriel S, Kremers H. Time Trends in Epidemiology and Characteristics of Psoriatic Arthritis Over 3 Decades: A Population-based Study. J Rheumatol 2009; 36: 361–367.10.3899/jrheum.080691Search in Google Scholar

6. Palotai T, Szepietowski JC, Pec J, Arenberger P, Giurcaneanu C, Gyulai R, Miljkovic J, Parna E, Mikazans I, Grusauskas N, Hodik M. A survey of disease severity, quality of life, and treatment patterns of biologically naive patients with psoriasis in central and eastern Europe. Acta Dermatovenerol Croat 2010; 18(3): 151-161.Search in Google Scholar

7. Mikuls T, Cannella A, Moore G, Erickson A, Thiele G, O'Dell J. Rheumatology: A Color Handbook. London: Manson Publishing Ltd; 2013. ISBN 97-818407-6173-3.10.1201/b16350Search in Google Scholar

8. Kane D, Stafford L, Bresnihan B, FitzGerald O. A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience. Rheumatology 2003; 42: 1460–1468.10.1093/rheumatology/keg384Search in Google Scholar

9. Gladman DD. Psoriatic arthritis. Dermatol Ther 2009; 22: 40–55.10.1111/j.1529-8019.2008.01215.xSearch in Google Scholar

10. Gladman DD. Early psoriatic arthritis. Rheum Dis Clin North Am 2012; 38(2): 373–386.10.1016/j.rdc.2012.05.005Search in Google Scholar

11. Moll J, Wright V. Psoriatic arthritis. Semin Arthritis Rheum 1973; 3(1): 55–78.10.1016/0049-0172(73)90035-8Search in Google Scholar

12. Gisondi P, Girolomoni G, Sampogna F, Tabolli S, Abeni D. Prevalence of psoriatic arthritis and joint complaints in a large population of Italian patients hospitalised for psoriasis. Eur J Dermatol 2005; 15(4): 279–283.Search in Google Scholar

13. McGonagle D, Ash Z, Dickie L, McDermott M, Aydin S. The early phase of psoriatic arthritis. Ann Rheum Dis 2011; 70(Suppl 1): 71–76.10.1136/ard.2010.14409721339224Search in Google Scholar

14. Gelfand JM, Gladman DD, Mease PJ, Smith N, Margolis DJ, Nijsten T, Stern RS, Feldman SR, Rolstad T. Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol 2005; 53: 573–577.10.1016/j.jaad.2005.03.04616198775Search in Google Scholar

15. Gladman D, Antoni C, Mease P, Clegg D, Nash P. Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis 2005; 64 (Suppl II): 14–17.10.1136/ard.2004.032482176687415708927Search in Google Scholar

16. Bielik J, Rovensky J. Nove moznosti biologickej liecby v reumatologii - reumatoidna artritida, psoriaticka artritida a ankylozujuca spondylitida. Farmakoekonomika a liekova politika 2010; 6(1): 11–19.Search in Google Scholar

17. Hanova P, Pavelka K, Holcatova I, Pikhart H. Incidence and prevalence of psoriatic arthritis, ankylosing spondylitis, and reactive arthritis in the first descriptive population-based study in the Czech Republic. Scandinavian journal of rheumatology 2010; 39(4): 310–317.10.3109/0300974090354421220476864Search in Google Scholar

18. Pec J, Palotai T, Simaljakova M, Zaujec L, Polak I, Psotova M, Vrtikova E, Salkovska J, Hemza M, Vojtas I, Urbancek S, Sevc J, Martinaskova K, Pecova K, Tindirova M, Martinaskova K, Surnakova K, Jautova J, Baloghova J, Linkesova E, Drotarova K. Epidemiologicka studia psoriazy v skupine biologicky naivnych pacientov v podmienkach Slovenska. Biologicka lecba 2011; 4(1): 15–22.Search in Google Scholar

19. Mease PJ, Armstrong AW. Managing Patients with Psoriatic Disease: The Diagnosis and Pharmacologic Treatment of Psoriatic Arthritis in Patients with Psoriasis. Drugs 2014; 74(4): 423–441.10.1007/s40265-014-0191-y395881524566842Search in Google Scholar

20. Helliwell PS, FitzGerald O, Fransen J, Gladman DD, Kreuger GG, Callis-Duffin K, McHugh N, Mease PJ, Strand V, Waxman R, Azevedo VF, Beltran Ostos A, Carneiro S, Cauli A, Espinoza LR, Flynn JA, Hassan N, Healy P, Kerzberg EM, Lee YJ, Lubrano E, Marchesoni A, Marzo-Ortega H, Porru G, Moreta EG, Nash P, Raffayova H, Ranza R, Raychaudhuri SP, Roussou E, Scarpa R, Song YW, Soriano ER, Tak PP, Ujfalussy I, de Vlam K, Walsh JA. The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project). Ann Rheum Dis 2013; 72(6): 986–991.10.1136/annrheumdis-2012-20134122798567Search in Google Scholar

21. Husni M, Meyer K, Cohen D, Mody E, Qureshi A. The PASE questionnaire: pilot-testing a psoriatic arthritis screening and evaluation tool. J Am Acad Dermatol 2007; 57(4): 581–587.10.1016/j.jaad.2007.04.00117610990Search in Google Scholar

22. Gladman D, Schentag C, Tom B, Chandran V, Brockbank J, Rosen C, Farewell V. Development and initial validation of a screening questionnaire for psoriatic arthritis: the Toronto Psoriatic Arthritis Screen (ToPAS). Ann Rheum Dis 2009; 68(4): 497–501.10.1136/ard.2008.08944118445625Search in Google Scholar

23. Fredriksson T, Petterson U. Severe psoriasis - oral therapy with a new retinoid. Dermatologica 1978; 157: 238-44.10.1159/000250839357213Search in Google Scholar

24. Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H. Classification Criteria for Psoriatic Arthritis. Arthritis and Rheumatism 2006; 54(8): 2665–2673.10.1002/art.2197216871531Search in Google Scholar

25. Queiro, R., Tejon, P., Alonso, S., & Coto, P. Age at disease onset: a key factor for understanding psoriatic disease. Rheumatology (Oxford) 2014; 53(7): 1178–1185.10.1093/rheumatology/ket36324273020Search in Google Scholar

26. Langley R, Krueger G, Griffiths C. Psoriasis: epidemiology, clinical features, and quality of life. Ann Rheum Dis 2005; 64: 18–23.10.1136/ard.2004.033217176686115708928Search in Google Scholar

27. Shlyankevich J, Mehta NN, Krueger JG, Strober B, Gudjonsson JE, Qureshi AA, Tebbey PW, Boer Kimball A. Accumulating Evidence for the Association and Shared Pathogenic Mechanisms between Psoriasis and Cardiovascular – Related Co-morbidities. Am J Med 2014; 127(12): 1148-1153.10.1016/j.amjmed.2014.08.008425984125149424Search in Google Scholar

28. Wu S, Han J, Li W, Qureshi AA. Hypertension, Anti-Hypertensive Medication Use, and Risk of Psoriasis. JAMA Dermatol 2014; 150(9): 957-963.10.1001/jamadermatol.2013.9957418420624990147Search in Google Scholar

29. Ceovic R, Mance M, Bukvic Mokos Z, Svetec M, Kostovic K, Stulhofer Buzina D. Psoriasis: Female Skin Changes in Various Hormonal Stages throughout Life—Puberty, Pregnancy, and Menopause. BioMed Research International 2013; doi: 10.1155/2013/571912. Epub 2013 Dec 28, 2013, 2013:571912: 1–6.Search in Google Scholar

30. Fry L. An Atlas of Psoriasis. Second edition. London: Taylor and Francis; 2004. ISBN 18-5070-410-4.Search in Google Scholar

31. Burden A, Javed S, Bailey M, Hodgins M, Connor M, Tillman D. Genetics of Psoriasis: Paternal Inheritance and a Locus on Chromosome 6p. Molecular Genetics of Psoriasis 1998; 110(6): 958–960.10.1046/j.1523-1747.1998.00213.x9620305Search in Google Scholar

32. Menter A, Gottlieb A, Feldman SR, Van Voorhees AS, Leonardi CL, Gordon KB, Lebwohl M, Koo JYM, Elmets CA, Korman NJ, Beutner KR, Bhushan R. Guidelines of care for the management of psoriasis and psoriatic arthritis. J Am Acad Dermatol 2008; 58: 826–850.10.1016/j.jaad.2008.02.03918423260Search in Google Scholar

33. Finlay AY. Current Severe Psoriasis and the Rule of Tens. The British Journal of Dermatology 2005; 152(5): 861–867.10.1111/j.1365-2133.2005.06502.x15888138Search in Google Scholar

34. Mrowietz U, Kragballe K, Reich K, Spuls P, Griffiths CEM, Nast A, Franke J, Antoniou C, Arenberger P, Balieva F, Bylaite M, Correia O, Dauden E, Gisondi P, Iversen L, Kemeny L, Lahfa M, Nijsten T, Rantanen T, Reich A, Rosenbach T, Segaert S, Smith C, Talme T, Volc-Platzer B, Yawalkar N. Definition of treatment goals for moderate to severe psoriasis: a European consensus. Arch Dermatol Res 2011; 303: 1–10.10.1007/s00403-010-1080-1301621720857129Search in Google Scholar

35. Poulin Y, Wasel N, Chan D, Bernstein G, Andrew R, Fraquelli E, Papp K. Evaluating practice patterns for managing moderate to severe plaque psoriasis. Can Fam Physician 2012; 58: 390–400.Search in Google Scholar

36. Helmick CG, Lee-Han H, Hirsch SC, Baird TL, Bartlett CHL. Prevalence of Psoriasis Among Adults in the U.S: 2003–2006 and 2009–2010 National Health and Nutrition Examination Survey. Am J Prev Med 2014; 47(1): 37–45.10.1016/j.amepre.2014.02.012465307724746373Search in Google Scholar

37. Polachek A, Touma Z, Anderson M, Eder L. Risk of Cardiovascular Morbidity in Patients With Psoriatic Arthritis: A Meta-Analysis of Observational Studies. Arthritis Care & Research 2017; 69(1): 67–74.10.1002/acr.2292627111228Search in Google Scholar

38. Dukat A, Lietava J, Luliak M, Krahulec B, Caprnda M, Vacula I. Epidemiologia nadvahy a obezity na Slovensku. Via Practica 2008; 3: 1–4.Search in Google Scholar

39. Armstrong AW, Harskamp CT, Armstrong EJ. The association between psoriasis and obesity: a systematic review and meta-analysis of observational studies. Nutrition and Diabetes 2012; 2: 1–6.10.1038/nutd.2012.26354243023208415Search in Google Scholar

40. Duarte GV, Porto da Silva L. Correlation between psoriasis’ severity and waist-to-height ratio*. An Bras Dermatol 2014; 89(5): 846–847.10.1590/abd1806-4841.20142854415597625184937Search in Google Scholar

41. Azfar RS, Gelfand JM. Psoriasis and metabolic disease: epidemiology and pathophysiology. Curr Opin Rheumatol 2008; 20(4): 416–422.10.1097/BOR.0b013e3283031c99374649418525354Search in Google Scholar

42. Langan SM, Seminara NM, Shin DB, Troxel AB, Kimmel SE, Mehta NN, Margolis DJ, Gelfand JM. Prevalence of metabolic syndrome in patients with psoriasis: A population-based study in the United Kingdom. J Invest Dermatol 2012; 132(3): 556–562.10.1038/jid.2011.365327849922113483Search in Google Scholar

43. Gisondi P, Galvan A, Idolazzi L, Girolomoni G. Management of moderate to severe psoriasis in patients with metabolic comorbidities. Front Med 2015; 2(1): 1–4.10.3389/fmed.2015.00001430099925654080Search in Google Scholar

44. Wolff JL, Starfield B, Anderson G. Prevalence, Expenditures, and Complications of Multiple Chronic Conditions in the Elderly. Arch Intern Med 2002; 162(20): 2269–2276.10.1001/archinte.162.20.226912418941Search in Google Scholar

45. Girolomoni G, Griffiths CEM, Krueger J, Nestle FO, Nicolas JF, Prinz JC, Puig L, Stahle M, van de Kerkhof PCM, Allez M, Emery P, Paul C. Early intervention in psoriasis and immune-mediated inflammatory diseases: A hypothesis paper. J Dermatolog Treat 2015; 26(2): 103–112.10.3109/09546634.2014.88039624547907Search in Google Scholar

46. Ranza R, Carneiro S, Qureshi AA, Martins G, Rodrigues JJ, Romiti R, Barros TB, Carneiro J, Sampaio AL, Grynszpan R, Markus J, Pinto RM, Goldenstein-Schainberg C. Prevalence of psoriatic arthritis in a large cohort of Brazilian patients with psoriasis. J Rheumatol 2015; 42(5): 829–834.10.3899/jrheum.14047425729032Search in Google Scholar

47. Spelman L, Su JC, Fernandez-Penas P, Varigos GA, Cooper AJ, Baker CS, Lee M, Ring JM, Thirunavukkarasu K. Frequency of undiagnosed psoriatic arthritis among psoriasis patients in Australian dermatology practice. J Eur Acad Dermatol Venereol 2015; 29(11): 2184–2191.10.1111/jdv.1321026370225Search in Google Scholar

48. Ogdie A, Langan S, Love T, Haynes K, Shin D, Seminara N, Mehta NN, Troxel A, Choi H, Gelfand JM. Prevalence and treatment patterns of psoriatic arthritis in the UK. Rheumatology 2013; 52: 568-575.10.1093/rheumatology/kes324357327023221331Search in Google Scholar

49. Busse K, Liao W. Which Psoriasis Patients Develop Psoriatic Arthritis?. Psoriasis Forum 2010; 16(4): 17–25.10.1177/247553031016a00403Search in Google Scholar

50. Walsh J, Callis Duffin K, Krueger G, Clegg D. Limitations in screening instruments for psoriatic arthritis: a comparison of instruments in patients with psoriasis. J Rheumatol 2013; 40(3): 287–293.10.3899/jrheum.12083623378465Search in Google Scholar

51. Coates LC, Aslam T, Al Balushi F, Burden AD, Burden-The E, Caperon AR, Cerio C, Chattopadhyay C, Chinoy C, Goodfield MJD, Kay L, Kelly S, Kirkham BW, Lovell CR, Marzo-Ortega H, McHugh N, Murphy R, Reynolds NJ, Smith CH, Stewart EJC, Warren RB, Waxman R, Wilson HE, Helliwell PS. Comparison of three screening tools to detect psoriatic arthritis in patients with psoriasis (CONTEST study). Br J Dermatol 2013; 168(4): 802–807.10.1111/bjd.1219023311587Search in Google Scholar

52. Tom B, Chandran V, Farewell V, Rosen C, Gladman D. Validation of the Toronto Psoriatic Arthtitis Screen Version 2 (ToPAS2). J Rheumatol 2015; 42(5): 841–846.10.3899/jrheum.14085725834198Search in Google Scholar